Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea

References 

1. World Health Organization . 10 facts on the global burden of disease. 2008;[accessed October 28, 2008] http://www.who.int/features/factfiles/global_burden/en/index.html
2. Ministry for Health, Welfare and Family Affairs . Annual Report of cancer incidence (2003) in Korea. 2008;
3. Ministry for Health, Welfare and Family Affairs . Annual Report of cancer incidence (2004) in Korea. 2008;
4. Ministry for Health, Welfare and Family Affairs . Annual Report of cancer incidence (2005) and survival (1993–2005) in Korea. 2008;
5. Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. Eur J Cancer Care. 2008;17:136–144
6. National Cancer Center . Evaluation of cancer screening and cost of cancer. 2006;
7. Greenberg ER, Chute CG, Stukel T, Baron JA, Freeman DH, Yates J, et al. Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med. 1988;318:612–617
   • MEDLINE
   • CrossRef
8. Carlson JJ, Garrison LP, Ramsey SD, Veenstra DL. The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer. Value Health. 2008;
9. Kim SG, Park WS. Out-of-pocket health expenditures among adult Koreans with cancer. Korean J Med. 2006;70:61–68
10. National Institutes of Health . National Center for Complementary and Alternative Medicine. What is CAM?. 2008;[accessed November 15, 2008]. http://nccam.nih.gov/health/whatiscam/
11. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–1330
    • CrossRef
12. Korea Institute for Health and Social Affairs . The Third Korea National Health and Nutrition Examination Survey (KNHANES III). 2006;
13. Chang SB. Cost analysis and classification of complementary and alternative therapies used by cancer patients in Korea. Yonsei University; 2005;
14. Kim CB, Yeh BH, Park JH. Understanding cancers patients who seek complementary & alternative therapies and searching developments of its management in South Korea. Ministry for Health, Welfare and Family Affairs; 2008;
15. Korea National Statistics . Korean Statistical Information Service. 2008;[assessed November 18, 2008] http://www.kosis.kr/eng/index.html
16. Kim JS, Lee MJ, Kim TH, Kwon TH, Park SC. The amount of unpaid work, monetary valuation and satellite account of national product. The Ministry of Gender Equality; 2005;
17. Bank of Korea . Economic Statistics System. 2008;[assessed November 20, 2008]. http://ecos.bok.or.kr
18. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246–252
    • MEDLINE
    • CrossRef
19. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40:[IV-104-IV-117]
20. Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States: 2000–2020. J Natl Cancer Inst. 2008;100:1763–1770
    • CrossRef